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REVIEW
Smartphones in mental health: a critical 
review of background issues, current status 
and future concerns
Michael Bauer1* , Tasha Glenn2, John Geddes3, Michael Gitlin4, Paul Grof5,6, Lars V. Kessing7, Scott Monteith8, 
Maria Faurholt‑Jepsen7, Emanuel Severus1 and Peter C. Whybrow4
Abstract 
There has been increasing interest in the use of smartphone applications (apps) and other consumer technology in 
mental health care for a number of years. However, the vision of data from apps seamlessly returned to, and inte‑
grated in, the electronic medical record (EMR) to assist both psychiatrists and patients has not been widely achieved, 
due in part to complex issues involved in the use of smartphone and other consumer technology in psychiatry. These 
issues include consumer technology usage, clinical utility, commercialization, and evolving consumer technology. 
Technological, legal and commercial issues, as well as medical issues, will determine the role of consumer technology 
in psychiatry. Recommendations for a more productive direction for the use of consumer technology in psychiatry are 
provided.
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Background
A smartphone is a transformational technology. The 
many benefits include instant communications and 
access to information from anywhere while using a sim-
ple, graphical, finger-based interface. One smartphone 
eliminates the need to carry many devices including a 
phone, camera, speakers, WiFi adapter, and a GPS sys-
tem. A smartphone allows the user to download and 
run applications (apps). The built-in sensors can provide 
measurements and contextual information, and by inte-
grating communications into an app, the user needs few 
connectivity skills. In 2012, a consumer smartphone had 
more than 100 times the computing power of the average 
satellite (NASA 2012).
Many thought the use of a smartphone in psychiatry 
would enable new measures of patient mental state and 
behavior to assist with patient screening, diagnosis, mon-
itoring and treatment (Glenn and Monteith 2014a; Mohr 
et  al. 2017; Luxton et  al. 2011), such as for bipolar dis-
order (Faurholt-Jepsen et  al. 2014, 2018; Harrison et  al. 
2016). The future is often envisioned in which actionable 
data from apps, both recommended by psychiatrists and 
selected by patients, are seamlessly returned to the EMR, 
and data from the apps would provide clinically useful 
measures to the physician and immediate feedback to 
assist patients. Although there are many mental health 
apps available for smartphones, their expected value has 
not been realized. This paper will discuss some of the 
complex reasons why the smartphone has not reached 
this potential for collecting patient data in psychiatry. 
Consumer technology usage, clinical utility, commerciali-
zation, and evolving consumer technology will be dis-
cussed, followed by recommendations to enhance the use 
of consumer technology in psychiatry.
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Consumer technology usage
Smartphone use is not universal
Smartphone use varies throughout the world. From a 
global perspective, in 2017 there were 5 billion unique 
mobile subscribers with 57% of connections using a 
smartphone (GSMA 2018a). For the 5 billion mobile 
subscribers, the top 3 uses of a cellphone are to make 
or receive cellular calls, send or receive text messages 
(SMS), and use messaging apps, while downloading and 
using apps for purposes other than messaging is ranked 
number 9 (GSMA 2018b). In 2018, 95% of the US popula-
tion owned a cellphone, and 77% of the cellphones were 
smartphones (Pew Research 2018). The percentage of 
cellphones that are smartphones in the US has remained 
constant since 2016 (Pew Research 2018).
Worldwide, smartphone use is unevenly distributed 
across the population. Older people use a smartphone 
significantly less often than younger people (Beren-
guer et  al. 2017). In the US, about 40% of community 
dwelling adults age 65 years or older own a smartphone 
(Anderson and Perrin 2017) with barriers to use includ-
ing visual and physical impairments (Kuerbis et al. 2017; 
Bauer et  al. 2018a). Additionally, older people often use 
a smartphone as a standard feature phone, making calls 
but never downloading apps (Berenguer et al. 2017). Peo-
ple with low income may only have intermittent access 
to smartphones (Gonzales 2016). Smartphone use by 
those with serious mental illness is generally lower than 
for the general population (Klee et  al. 2016; Glick et  al. 
2016; Abu Rahal et al. 2018; Carpenter-Song et al. 2018). 
Smartphone use is also associated with more education 
(Pew Research 2018).
Alternatives to smartphones
Consumers own many technologies in addition to a 
smartphone. In the US, in 2018, 73% of the population 
owned a desktop or laptop, and 53% owned a tablet (Pew 
Research 2018). Most owners of desktops or laptop also 
own peripheral devices such as printers and scanners. 
People use smartphones and desktops/laptops for dif-
ferent daily activities, varying by age (Bröhl et al. 2018). 
Although younger generations use a smartphone most 
frequently to perform daily activities, all age groups in 
an international sample preferred to use a desktop PC/
laptop for writing emails or letters, and for passing on 
confidential information (Bröhl  et al. 2018). In an inter-
national sample of patients with bipolar disorder, 81% 
looked for information on the Internet, with 89% of these 
preferring to search from a desktop/laptop (Conell et al. 
2016).
Wearables
In 2018, about 20% of adult Americans used wearable 
technology at least once a month (Statistica 2019c). 
Wearable technology refers to accessories and clothing 
incorporating computer technologies, including smart 
watches, fitness trackers, smart clothing, and ear-worn 
devices (Godfrey et al. 2018). Smart watches and fitness 
trackers are the most popular wearables (Gartner 2018), 
and sales are growing rapidly (IDC 2019). Wearables are 
playing an increasing role in healthcare (Amft 2018), 
including mental health (Behar et al. 2019). Many smart-
phone apps connect to sensors in wearable technologies 
(research2Guidance 2018). For example, Abilify MyCite 
are aripiprazole pills with an embedded sensor that com-
municates to a wearable patch when ingested, which then 
transmits data to a smartphone app (FDA 2017a).
Medical apps from the app stores
The app stores offer trusted one-stop shopping for con-
sumers to obtain software for their smartphone’s oper-
ating system, few entry barriers for app developers, and 
instant credibility for small developers (Deloitte 2018). 
Apple and Google dominate the distribution of apps from 
their stores. In 2018, there were 2.1 million apps in the 
Android store and 2 million apps in the Apple store (Sta-
tistica 2019a). The number of health apps and health app 
publishers keeps growing. In 2017, there were 325,000 
health apps available from 84,000 health app publishers, 
with about 78,000 apps added in the last year (research-
2guidance 2018). The majority of apps are developed by 
technology companies or app developers outside of the 
healthcare industry (research2guidance 2016; Ahmed 
et al. 2018). Most health apps have less than 5000 yearly 
downloads (research2guidance 2017). The selection of 
mental health apps available in the app stores is con-
stantly changing. In a 9-month study of apps available in 
Australian Google Play and Apple iTunes stores related 
to depression, bipolar disorder and suicide, 50% of results 
changed after 4 months with an app being removed every 
2.9 days (Larsen et al. 2016b).
App retention rates
The user retention rate for smartphone apps in the gen-
eral population is low. About 25% of users abandon apps 
after one use (Rodde 2019). For both Android and Apple 
smartphones, the app retention rate worldwide after 
90 days was just 4% in 2016 (Statistica 2019b). Even the 
wildly popular Pokémon Go app dropped 80% of users in 
a few months (comScore 2017a).
Similarly, reports for health apps, including mental 
health related, show limited downloads and poor reten-
tion, especially outside of clinical trials and research 
settings. In national surveys in Germany, 20.5% of adult 
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smartphone users 35  years or older, and 16.5% older 
adults used a health app (Ernsting et  al. 2017; Rasche 
et  al. 2018). In a national survey of smartphone users 
in the US, 58% had downloaded a health app but about 
half had stopped using it (Krebs and Duncan 2015). In 
other studies using national data, people who used health 
apps were younger, richer and in excellent health (Car-
roll et al. 2017), and a heath app was downloaded by 12% 
of those with depression (Robbins et  al. 2017). In stud-
ies of patients with mental illness, a mental health app 
was downloaded by 10.7% at a VA facility (Lipschiz et al. 
2019). About 10% of patients both at a state clinic and 
at a private insurance clinic were using a mental health 
app (Torous et al. 2018). A review of digital self-help apps 
or programs for depression and anxiety, involving 8 to 
40,000 downloads or registrations per month, reported 
21–88% using at least once, and 0.5–28.6% continu-
ing after 6 weeks (Fleming et al. 2018). Only 18.7% of a 
US Hispanic/Latino population enrolled in a depression 
clinical trial downloaded the treatment app (Pratap et al. 
2018).
Selective use and low retention rates directly affects 
research. Data collected from apps or social media are 
generally not representative of the national population, 
people with mental illness, or of people with a specific 
condition (Monteith and Glenn 2016). Additionally, with 
the low retention rates, researchers using a dataset from 
the same app or social media platform at different times 
may be investigating different user populations (Althoff 
2017).
While some patients will use and benefit from mental 
health apps, all consumer technologies have selective use 
and low retention rates. High interest in mental health 
apps will not automatically lead to high use (Torous et al. 
2018). Mental health app retention may be improved by 
using the app in clinical settings and providing a free 
smartphone and data plan (Faurholt-Jepsen et  al. 2015, 
2019; Achtyes et  al. 2019). Given that only about 50% 
of patients take medications as prescribed (Brown and 
Bussell 2011), expectations for the use of recommended 
medical apps should not be overly optimistic.
Selection of mental health apps
Most consumers find mental health apps through social 
media, web searches or word of mouth rather than by 
professional recommendation (Schueller et  al. 2018). 
Smartphone owners often rely on online app reviews 
but these can be misleading. For example, none of the 
25 most popular iPhone apps for anxiety and worry, as 
indexed by user ratings, included content consistent with 
evidence-based treatments (Kertz et al. 2017). Users gave 
high reviews to a very popular but inaccurate blood pres-
sure app that was withdrawn from the market (Plante 
et al. 2018). Patients and physicians may have a different 
perspective on the quality or usability of apps (Singh et al. 
2016, 2019), including for bipolar disorder (Nicholas 
et al. 2015). In a study of top ranked mental health apps 
from Google Play and iTunes stores, scientific language, 
not direct evidence, was the most frequently employed 
strategy to support claims of effectiveness (Larsen et  al. 
2019). Additionally, there are many services for unscru-
pulous app developers to game the app review process, 
such as by paying users to write reviews (Hill 2018).
Attitudes towards apps and wearables
People have varied attitudes towards the use of apps and 
wearables. Many people with chronic medical illness 
reject self-monitoring, finding it annoying, depressing, 
a burden, or prefer to forget they are ill (Lupton 2013; 
Bauer et al. 2017). The very process of measurement may 
hinder enjoyment of physical activities and decrease well-
being (Toner 2018; Etkin 2016). Some may fixate on one 
measure, such as a step count, and ignore other health 
related issues (Felde 2019). Patients with mental illness 
may prefer apps that support relaxation and time man-
agement, rather than apps that directly target their dis-
orders (Dragovic et al. 2018). Some feel that the privacy 
risks associated with wearable devices pose a threat to 
their health and well-being (Marakhimov and Joo 2017). 
Some feel they are being increasingly asked to rely on 
their own observations and online findings, and view 
this as being outside the traditional healthcare system 
(Vesnic-Alujevic et  al. 2018). Many of the patients who 
do not use mental health apps may prefer direct, personal 
contact with a psychiatrist.
Clinical utility
Issues with regulation of apps and wearables
In the US, very few medical apps and wearables, includ-
ing for mental health, require FDA review. Regulation 
is limited primarily to software that is an accessory to a 
regulated medical device, or that will transform a mobile 
platform into a regulated medical device (Davis 2017; 
FTC 2016). The vast majority of medical apps that pose 
“minimal risk” to a user are outside of FDA enforcement. 
For example, mental health apps that help to self-manage 
but do not claim to diagnose or provide specific treat-
ment suggestions would pose “minimal risk” (FTC 2016; 
Armontrout et  al. 2018). Even with software devices 
that require FDA review, under the FDA Digital Health 
Software Pre-certification Program, the manufacturer, 
not the actual software product, is certified based on a 
company culture of software quality and commitment to 
patient safety (Terry 2019). Although post-market sur-
veillance is required, consumers and physicians may not 
realize that FDA pre-certification does not necessarily 
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mean that products were proven safe and effective before 
release (Lee and Kesselheim 2018). An unforeseen result 
of this regulatory policy may be the release of consumer 
products deemed controversial by physicians, such as the 
use of Apple Watch to detect undiagnosed atrial fibril-
lation (Mandrola and Foy 2019; Packer 2019; Rowland 
2018). Lack of regulation of medical and mental health 
apps is a growing international problem (Parker et  al. 
2019).
Measurement accuracy of apps and wearables
Sensors in smartphones and wearables offer the potential 
for physiological measurement and remote monitoring 
(Lowe and Ólaighin 2014). However, measurement inac-
curacies are frequently reported including overestima-
tion, underestimation, high variability, misclassification 
of results, and lack of agreement with gold standards 
(Hwang 2018). See Tables  1 and 2. Frequent errors are 
related to properties of the embedded sensors and smart-
phone hardware, the medical apps, and the human use of 
smartphones and wearables.
The sensors embedded in smartphones and other con-
sumer devices are generally not professional grade due to 
manufacturing costs and power requirements, and may 
be inaccurate (Grewal and Andrews 2010; Puentes et al. 
2013; del Rosario et  al. 2015; Grammenos et  al. 2018). 
For example, there is sensor bias (defined as the average 
sensor output at zero sensor input) in the accelerometer 
and gyroscope, as measured in 61 smartphones includ-
ing models from Samsung, Apple, Huawei, and Sony 
(Kos et al. 2016). This bias must be calibrated and com-
pensated for by sensor type and model, especially in apps 
designed to run across multiple smartphone devices. 
Additionally, when the same sensor is embedded in a 
smartphone from a different manufacturer using a differ-
ent operating system, results may differ since sensor sig-
nals are processed by the operating system before being 
presented to the apps. Apps from different developers, 
which are based on the same sensor and run on the same 
device, may also provide different results due to different 
software programming techniques.
Table 1 Accuracy problems in studies using physiological measurements by smartphone apps
Measure App Smartphone Participants Finding Study
Blood pressure Instant Blood Pressure iPhone 5 and 6. 85 patients and staff; 
53% with hyperten‑
sion.
Measures “were highly 
inaccurate”
Plante et al. (2016)
Heart rate Instant Heart Rate
Heart Fitness
Whats My Heart Rate
Cardio Version
iPhone 4 and 5. 108 patients, exluding 
those in critical condi‑
tion.
“substantial performance 
differences” between 
the four apps
Coppetti et al. (2017)
Heart rate
Blood pressure
Oxygen saturation
Instant Blood Pressure
Instant Blood Pressure 
Pro
Pulse Oximeter
Pulse oximeter Pro
iPhone 5S 100 healthy participants “applications evaluated 
do not provide clini‑
cally meaningful data” 
“inaccurate data.. can 
potentially contribute 
to patient harm”
Alexander et al. 
(2017)
Heart rate Runtastic Heart Rate 
Monitor
Instant heart rate+
iPhone 15 regularly active col‑
lege students
“Poor correlation to ECG” 
during moderate to 
high intensity exercise
Bouts et al. (2018)
Step counting Argus: calorie counter 
and step
Android phones: Sam‑
sung, OnePlus, Moto, 
Oppo, Galazy, Huawei, 
LG, Google, Sony and 
Agora running Android
4.4 to 8.1
Apple: iPhone 6, 6S, 7, 8, 
running iOS10.3–11.4.
48 healthy participants “extraordinarily large 
error ranges for both..
phones”
“appear unsuitable to 
detect steps in short, 
slow, or non‑stereotyp‑
ical gait patterns”
Brodie et al. (2018)
Sleep Sleep time iPhone 4 s and 5 20 participants with no 
sleep disorder
“absolute parameters 
and sleep staging…. 
correlate poorly with 
polysomnography”
Bhat et al. (2015)
Sleep MotionX 24/7 iPhone 4 78 children and adoles‑
cents with suspected 
sleep disordered 
breathing
“did not accurately reflect 
sleep or wake and 
should be used with 
caution”
Toon et al. (2016)
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The sensors that are embedded in smartphones often 
change over time, which may lead to varying measure-
ment results. From a manufacturing perspective, all 
components of a smartphone including sensors may 
have cost or power saving revisions through a variety of 
approaches including part substitution (using a different 
part with identical or similar form, fit and function), and 
by redesign (upgrading the system to utilize newer parts) 
(Solomon et  al. 2000). As a smartphone goes through 
its product life cycle, it is very likely that components, 
including sensors, for the same model have been revised, 
which may change measured results. Additionally, spe-
cific models of smartphones have a short lifespan with 
new models often introduced yearly. When smartphone 
models change, it is very likely that hardware compo-
nents including sensors will change and software must 
be recalibrated (Li et al. 2010; del Rosario et al. 2015; Kos 
et  al. 2016). The sensors used in wearables also change 
frequently and will result in inconsistent data collection 
(Amft and Van Laerhoven 2017).
Hardware features of the smartphone itself can influ-
ence measurements including power consumption, 
processor speed, smartphone size, the position of sen-
sor in the device, and sensor ability to handle noisy 
indoor and outdoor environmental conditions (Parpi-
nel et  al. 2017; Agu et  al. 2013; GPS 2017). Individual 
actions also may impact measurement accuracy such as 
where and how a smartphone is held (Agu et al. 2013; 
Vezočnik and Juric 2019), and not following instruc-
tions on how to use an app. Patients may forget to 
charge a smartphone, stop using sensor based apps to 
preserve battery life, turn off the smartphone, be out 
of range for data transmission, or loan the phone to 
another person (Agu et al. 2013; Boonstra et al. 2018). 
Similar problems also occur with wearables. A review 
of 67 studies of Fitbit devices found that other than 
measures of steps in adults without mobility limita-
tions, the device is unlikely to provide sufficiently accu-
rate measurement for clinical medicine or research 
(Feehan et al. 2018).
The various revisions of sensors and models for the 
smartphone and other devices are of major concern since 
the vast majority of apps are not regulated by the FDA 
as a medical device. A traditional medical device would 
Table 2 Accuracy problems in studies using physiological measurements by wearables
Measure Number tested Wearables Patients Finding Study
Total energy 
expendi‑
ture
12 devices Withings Pulse
Jawbone
Garmin Vivofit
Suzuken Lifecorder EX
Panasonic Actimaker
Epson Pulsense
Tanita‑AM‑160
Fitbit Flex
Misfit Shine
Omron Active Style Pro
Omron CaloriScan
19 healthy adults, not obese. “absolute values differed 
widely among products and 
varied significantly from the 
gold standard measures”
Murakami et al. (2016)
Step count 3 pedometers Yamax
Digiwalker
Fitbit
14 young health participants 
walking at 3 speeds
“all the evaluated devices had 
high error rates at 1 km/h” 
(slow walking speeds).
Beevi et al. (2016)
Step count 10 activity trackers Polar Loop
Garmin Vivosmart
Fitbit Charge HR
Apple Watch Sport
Pebble Smartwatch
Samsung Gear S
Misfit Flash
Jawbone Up Move
Flyfit
Moves
31 healthy participants on a 
treadmill
“Test–retest validity depends 
on walking speed”; “con‑
sumer activity trackers per‑
form better at average and 
vigorous walking speed…”
Fokkema et al. (2017)
Sleep 2 monitors Withings Pulse
Jawbone Up
36, including 22 with obstruc‑
tive sleep apnea (OSA)
“confirmed… in patients suf‑
fering from OSA, the limited 
performance of wearable 
sleep monitors”
Gruwez et al. (2019)
Sleep 2 monitors Fitbit Change 2
Neuroon
25 students Underestimate light sleep and 
overestimate deep sleep. 
“Reasonably satisfactory for 
general purpose and non‑
clinical use”
Liang and Martell (2018)
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require testing, validation and recertification by a regula-
tory body after a hardware or software change that may 
be critical to safety or efficacy, before the modified device 
is released to the public (FDA 2017b).
Blue light exposure
Measurement using smartphone apps and small devices 
is also a concern because light-emitting diode (LED) 
backlights are used to enhance daytime brightness and 
contrast of displays (Gringras et al. 2015; Oh et al. 2015). 
Unlike conventional lighting, LEDs emit bright blue light 
at a wavelength close to the peak sensitivity for non-visual 
circadian photoreception (Gringras et al. 2015; Oh et al. 
2015). In studies primarily of healthy volunteers, expo-
sure to blue light may disrupt a variety of circadian func-
tions (Tosini et al. 2016; Bauer et al. 2018b), even at low 
intensities (Prayag et al. 2019). For example, even “night-
time” settings on devices may emit light far above the 
predicted threshold for melatonin suppression (Prayag 
et  al. 2019). When a smartphone is used as a measur-
ing device, exposure to blue light can directly impact the 
patient and influence the measurement of a wide range of 
variables including alertness, cognition, sleep, and activ-
ity levels. Without understanding if exposure to blue light 
from smartphones, other devices, or ambient lighting is 
impacting what is being measured, data collected are dif-
ficult to interpret (Bauer et al. 2018b).
Efficacy not proven
A lack of efficacy of smartphone apps and wearables 
extends throughout medicine. A Cochrane review of 
automated telephone communication systems, often 
smartphone based, included 132 clinical trials and over 
4 million participants across specialties (Posadzki et  al. 
2016). Positive effects were found from reminders, 
including increased prevention screenings and appoint-
ment attendance, while other effects varied by condi-
tion with “little or no effect” in mental health (Posadzki 
et al. 2016; Foster and Callans 2017). Table 3 summarizes 
systematic reviews of apps related to mental health that 
are available to consumers. While many studies discuss 
the potential of mental health apps, there is little clini-
cally validated evidence. For example, a review of 100 
studies that used a mental health app for a wide range 
of conditions, only 14 had clinically validated evidence 
(Wang et  al. 2018). Additionally, reviews that focus on 
the mental health apps with controlled trials generally 
have conclusions such as promising but little evidence 
today, studies of mixed quality, and more, larger trials 
needed (Dogan et al. 2017; Byambasuren et al. 2018; Firth 
and Torous 2015; Wang et al. 2018). However, given the 
low cost of entry for app developers, the vast majority 
will never be able to afford even a simple clinical trial 
to establish efficacy (Foster and Callans 2017). This is a 
major challenge: how do we test the effectiveness of these 
applications in a timely, robust and cost-effective man-
ner? Are clinical trials always necessary? Answering these 
questions is critical and will need considerable methodo-
logical innovation.
Passive monitoring
Some apps focus primarily on using a smartphone for 
ongoing passive monitoring of individuals with mental 
illness. Passive monitoring collects data from patients 
without requiring direct patient input, often using only 
sensors to measure a wide range of variables such as 
activity level, mobility, physiological measures, speech 
patterns, and signals of social interactions (Abdullah 
and Choudhury 2018). Reviews of passive monitoring 
report similar conclusions, that results are promising 
but many methodological and interpretive challenges 
remain, larger trials are needed, and evidence in clini-
cal settings is lacking (Faurholt-Jepsen et  al. 2018; Cor-
net and Holden 2018; Seppälä et  al. 2019; Rohani et  al. 
2018; Goodday and Cipriani 2019). In addition to the 
hardware and software concerns, there are special con-
cerns with passive monitoring related to stigma and pri-
vacy (Bauer et al. 2017). Of patients interested in apps, a 
significant minority does not want to be monitored and 
tracked or provide private sensor-based data (Thornton 
and Kay-Lambkin 2018; Klasnja et al. 2009; Torous et al. 
2018; Ben-Zeev et al. 2016; Di Matteo et al. 2018; Hen-
drikoff et  al. 2019). In a study of mobile sensing of 126 
adults with depression recruited from the general public 
in Switzerland, half uninstalled the app within 2  weeks 
(Wahle et  al. 2016). Mood assessment by passive moni-
toring was not useful at the population level (Pratap et al. 
2019). Patient adherence with wearables is also a major 
problem (Amft 2018).
Ethical issues with mental health apps
There are many ethical issues associated with mental 
health apps. Apps are being widely promoted, often con-
taining incorrect information and with unproven efficacy. 
See Tables 1, 2 and 3. Mental health apps may promote 
unsafe and misleading messages. For example, poten-
tially harmful information was noted in apps about bipo-
lar disorder (Nicholas et  al. 2015), suicide (Larsen et  al. 
2016a) and alcohol use (Crane et  al. 2015). A study of 
64 frequently used mental health apps noted two recur-
ring themes: that fragile mental health is ubiquitous, and 
that individuals can easily manage mental health prob-
lems with apps (Parker et al. 2018). These messages may 
medicalize normal mental states, and be dangerous for 
those with diagnosed mental illness who need a clear 
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understanding of when to seek professional help (Parker 
et al. 2018). Problematic use of smartphones is associated 
with depression and anxiety, and mental health apps may 
not be appropriate (Elhai et al. 2017; Kim et al. 2015). Lax 
regulation may allow direct-to-consumer psychotherapy 
apps to connect users to minimally trained, nonprofes-
sional counselors (Martinez-Martin and Kreitmai 2018). 
Apps that connect patients to chatbots may provide 
incomplete responses to simple questions, have limited 
capacity to recreate human interactions or offer tailored 
treatment, and may not provide real time access to men-
tal health services when needed (Kretzschmar et al. 2019; 
Miner et al. 2016).
Another issue relates to recommending apps to patients 
without sufficient understanding of the patient’s techni-
cal competence, awareness of privacy issues, and ability 
to avoid online harm (Bauer et al. 2017; Torous and Rob-
erts 2017; Gangadharan 2017). Poor digital skills, lack 
of knowledge of online safety practices, individual traits 
associated with mental illness, and cognitive impairment 
all increase vulnerability to online fraud (Monteith and 
Glenn 2016; Gangadharan 2017; Sheng et al. 2010; Bauer 
et al. 2017, 2018a).
Commercialization
Commercial firms and the digital economy
As commercial firms play an increasing role in providing 
apps, wearables, and algorithms in medicine, it is impor-
tant to recognize that the digital economy is based on 
collecting and selling personal data (Bauer et  al. 2017). 
The dominant business model depends on violating pri-
vacy (Narayanan 2018) as commercial firms routinely 
track all individual online activities and habits (Glenn 
and Monteith 2014a; Monteith and Glenn 2016). Data 
are collected, combined with other data, and re-sold as 
data products. This commodification of consumer data 
includes data from medical apps and wearables, facial 
recognition, as well as biometrics used in authentication 
schemes (Elvy 2018; Roberts 2019). With this distributed 
and redundant data economy, one should assume that 
data cannot be permanently deleted (PCAST 2014).
Commercial, academic and governmental organiza-
tions purchase data, combine data with other data from 
all aspects of daily life, and create algorithms that are rou-
tinely used to classify people (Bauer et al. 2017; Monteith 
and Glenn 2016). The use of these classifications extends 
far beyond behavioral or personalized advertising, and 
sales of products “recommended for you” (Beales 2010). 
These algorithm classifications directly impact almost 
every aspect of daily life, including education, employ-
ment, credit, healthcare, criminal justice, and govern-
ment services (Monteith and Glenn 2016; Bauer et  al. 
2017). In the US, the market value of personal data was 
estimated at $76 billion in 2018, increasing 44.9% from 
2016 to 2018 (Shapiro and Aneja 2019). Most commer-
cial algorithms are proprietary and opaque, with this lack 
of transparency posing a variety of safety dangers (Bauer 
et al. 2019; ACM 2017; AI HLEG 2019). Despite the size, 
the big data basis for the classification may not be rep-
resentative of the general population, or of those with 
mental illness (Monteith et  al. 2016). Algorithmic deci-
sion-making based on big data may be incorrect, reflect 
human biases, and incorporate and perpetuate tradi-
tional social prejudices and stigmas (Monteith and Glenn 
2016; Executive Office 2016; Partnership on AI 2019; AI 
HLEG 2019).
Individual discomfort with the digital economy
There is a major disconnect between corporate and indi-
vidual perspectives on the use of personal digital data. 
In a 2018 survey of adults in US, France, UK and Ger-
many, 75% now limit the personal information they share 
online, only 29% feel that providing data leads to better 
commercial products and services, and 60% found weara-
bles “creepy” (RSA 2019). In a 2018 survey of adults in 
the US, only 11% were willing to share health data with 
technology companies (Day and Zweig 2019). In a 2018 
survey of US Facebook users, 74% were unaware Face-
book was classifying them, 51% were uncomfortable 
with this and 27% said the classifications were inaccurate 
(Hitlin and Rainie 2019). In another 2018 survey in the 
US, about 60% thought algorithmic decision-making was 
unfair and that computer programs will always reflect 
human bias (Smith 2018). In a survey in Germany, users 
completely rejected sharing mental health information 
with commercial organizations for developing health rec-
ommender systems (Valdez and Ziefle 2019).
Privacy protection
Patients are very concerned about privacy (Torous et al. 
2018), and many are not comfortable providing personal 
data to clinicians via mobile apps (Dragovic et al. 2018). 
In the US, most apps fall outside of HIPAA protections, 
which only apply to traditional healthcare relationships 
and environments including healthcare providers, insur-
ers and their business associates (Cohen and Mello 2018; 
Gostin et  al. 2018). HIPAA does not cover patient-gen-
erated data from apps, wearables or the Internet, which 
is collected by firms and services that receive, store, 
combine, analyze and sell the data (Cohen and Mello 
2018; Glenn and Monteith 2014b; Monteith and Glenn 
2016; Gostin et  al. 2018). HIPAA also does not cover 
the diverse range of non-medical digital data that is rou-
tinely included in medically related algorithms (Glenn 
and Monteith 2014b). HIPAA does apply when data from 
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apps or wearables are sent to the EMR (Hughes 2019; 
MicroMD 2019). Although the European GDPR requires 
more robust accountability, some firms circumvent these 
rules as the data environment becomes increasingly 
internationalized (Gostin et al. 2018; Vinokur 2019; Scott 
et al. 2019).
Privacy policies
For most smartphone apps and wearables, the only pro-
tections provided to users are those included in the 
privacy policy. The requirement for apps to a provide pri-
vacy policy is increasing, but varies internationally and by 
app store. Studies that searched for apps after 2016 found 
that many lacked a privacy policy, as shown in Table  4. 
Based on a “notice and consent” model, a privacy policy 
offers the consumer a take-it-or-leave it choice to agree to 
the terms (PCAST 2014). Most people just agree without 
reading privacy policies, which are often unclear, writ-
ten at a post-secondary level with technical information 
embedded in legal language (PCAST 2014; Frazee et  al. 
2016; Robillard et al. 2019). Privacy policies for apps and 
wearables routinely authorize the sale, transfer, analysis 
and disclosure of consumer data to third parties (Elvy 
2018). For example, an analysis of network traffic and 
privacy policies of top rated Android apps for prescrip-
tion medications in Oct-Nov 2017, found that 19 of 24 
apps (74%) shared data with 55 unique third parties, who 
in turn could share with 216 fourth parties (Grundy et al. 
2019). The companies receiving this data included large 
tech companies, Alphabet/Google, Facebook and Oracle, 
and digital advertising firms, among others. In an analy-
sis of the 36 top-ranked apps for depression and smoking 
cessation in Jan 2018, 33 of the 36 apps (92%) shared data 
with a third party, and 29 of the 36 apps (81%) shared 
data with Google and Facebook (Huckvale et  al. 2019). 
Most privacy policies authorize the sale of personal data 
in the case of a merger, acquisition or bankruptcy (Elvy 
2018, Singer and Merrill 2015). This is pertinent since in 
the US about 90% of all business startups fail (Patel 2015), 
including 3 out of 4 venture backed firms (Gage 2012). 
Additionally, patterns detected in the analysis of large, 
diverse datasets may allow firms to infer medical condi-
tions and thus undermine the importance of individual 
consent (Barocas and Nissenbaum 2014).
Security issues for app or wearable data in EMR
As more data from patient apps are sent to the EMR, pro-
cedures must be in place to safely handle the data influx. 
Table 4 Studies of percent of apps searched 2016–2018 that provide a privacy policy
Apps in English
a Personnel communication
b Terms of agreement present for 15% of Apple and 3% of Android
c Apps in English of Indian origin
App search Source Dates of search Country of search Number of apps Percent 
with privacy 
policy (%)
Study
Depression Google Play, Apple 
iTunes store
Oct, 2017 US 116 49% O’Loughlin et al. 
(2019)
Depression Google Play, Apple 
App store
Oct–Nov, 2018 UK 353 74% Bowie‑DaBreo et al. 
2019
Depression and 
smoking cessation
“official Android and 
iOS marketplaces”
Jan, 2018 US and Australia 36 69% Huckvale et al. (2019)
“mood” and “track” Google Play, Apple 
App store
Jun–Aug, 2016; 
and Jan–Feb 
 2017a
Canada 319 IOS;
69 Android
18% for IOS; 4% 
 Androidb
Robillard et al. (2019)
Dementia Apple iTunes
store
Apr–May, 2016 US 72 46% Rosenfeld et al. (2017)
Specific diseases 
including mental 
illnesses
Google Play, Apple 
iTunes store
July 2018 US 40 each for anxiety, 
schizophrenia, 
depression, 
addiction
85%‑anxiety; 
50%‑schizophre‑
nia; 85%‑depres‑
sion;
70%‑addiction
Wisniewski et al. 
(2019)
Migraine Google Play, Apple 
App store, health‑
line.com
July–Aug, 2017 US 29 76% Minen et al. (2018)
Mental Health Google Play May–Jun, 2017 India 82c 35% Powell et al. (2018)
Increase physical 
activity
Google Play, Apple 
iTunes store
Oct, 2016 UK 65 70% Bondaronek et al. 
(2018)
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The healthcare industry is a frequent target of all forms 
of cyberattacks due to extreme vulnerability to disrup-
tion in services, and the ability for criminals to monetize 
the financial and health information contained in medi-
cal records (Argaw et al. 2019). These cyber attacks occur 
worldwide with major incidents reported in the US, UK 
and Norway (Charette 2018). In the US, data breaches 
increased between 2010 and 2017 and involved 176.4 
million patient medical records (McCoy and Perlis 2018). 
Ransomware is increasing rapidly (DOJ 2017), with 
healthcare the most targeted industry (Donovan 2018). 
Patient portals into EMR have also been compromised 
(HIPAA Journal 2017). The 2017 US Health Care Indus-
try Cybersecurity Task Force concluded that healthcare 
cybersecurity is in “critical condition” (HHS 2017). Yet 
IT spending as a percentage of revenue is much lower 
in healthcare compared with financial services, another 
industry that must focus on security (Computer Eco-
nomics 2019). This is illustrated when considering the 
IT spending per user, including both employees and 
non-employees, based on spending at the 25th and 75th 
percentiles. IT spending per user at the 25th percentile 
in financial services is $13,772, more than double that 
of healthcare at the 75th percentile at $6143 (Computer 
Economics 2019). Lower spending on IT in healthcare 
than financial services directly impacts security. Even 
if healthcare and financial services spend the same per-
centage of the IT budget on security, the dollar amount 
available in healthcare to obtain expensive IT security 
products and services is much lower (Computer Eco-
nomics 2019).
Individual discomfort with app and wearable data in EMR
Patient security concerns about EMR may impact disclo-
sure of personal information (Agaku et  al. 2014), use of 
patient portals, and use of apps or wearables that send 
data to an EMR. In US national surveys, about half the 
people had concerns about privacy and security of medi-
cal records (Patel et  al. 2016), and 25% of those offered 
a patient portal would not use due to privacy concerns 
(Patel and Johnson 2018). In a survey of 12,000 adults, 
nearly all were concerned that sensitive data such as 
mental health notes would be shared beyond their cho-
sen provider (Snell 2017). Also in this survey, 89% of 
patients withheld information, with 93% of these saying 
the reason was concerns over security of personal finan-
cial information. Between 31 and 38% of those surveyed 
in Canada and the UK said they would postpone seeking 
care due to privacy concerns (Fair Warning 2011a, b).
Evolving consumer technology
While we are currently in a technology era dominated 
by smartphones, this will not last. As predicted by Gor-
don Bell, leader of the minicomputer revolution at 
Digital Equipment Corporation, a new class of smaller 
computers is developed about every decade (Bell 2008). 
The primary computing platform has evolved from main-
frames to minicomputers, to workstations, to PCs, to 
laptops, to smartphones. For over 50 years, the basis for 
this change was the doubling of the number of transis-
tors per chip about every 2 years as predicted by Gordon 
Moore, cofounder of Intel (Moore 2006; Mack 2011). 
The computing platform will continue to evolve beyond 
smartphones with each new class being smaller and 
less expensive (Bell 2008). Indeed, mobile subscription 
sales are near saturation in the developed world (GSMA 
2018a), and smartphone sales have reached a plateau and 
started to decline (Savov 2019; Swearingen 2018).
In the future, apps will be controlled by voice. Voice 
interfaces to small, smart wearables including watches, 
fitness trackers, and ear-pads, are coming soon, as well as 
to smartphone apps, and a wide range of smart devices 
and home controls (Koetsier 2019). Miniaturized system 
components, including sensors and microprocessors with 
greatly reduced power and energy requirements, and new 
soft, flexible materials will enable ubiquitous sensing and 
computing (Lee and Lee 2017; Herbert et al. 2018). Voice 
assistants marketed today include Amazon Alexa, Google 
Assistant, Apple Siri, and Microsoft Cortana. The num-
ber of voice assistants in use worldwide is estimated to 
triple to 8 billion by 2023 becoming an $80 billion market 
(Perez 2019), while smart wearable device sales will dou-
ble to 233 million units by 2022, becoming a $27 billion 
market (Lamkin 2018). Consumer electronics shows are 
dominated by a wide range of voice activated products 
including TVs, toilets, lightbulbs, ovens, blinds, speakers 
and showers (Wiggers 2019). The complex issues of pri-
vacy, security and commercial involvement, accuracy and 
efficacy are increasing as consumer devices evolve.
These new voice-activated devices are predicted to 
replace many of the functions of today’s smartphone, 
and provide new functions that change how we live. In 
the words of Google CEO Sundar Pichai “Looking to 
the future, the next big step will be for the very concept 
of the “device” to fade away. Over time, the computer 
itself—whatever its form factor—will be an intelligent 
assistant helping you through your day” (Google 2016). 
The pace of adaption of new technologies has greatly 
accelerated, as it took 85 years for a telephone to become 
an integral part of life and only 13 years for a smartphone 
(Irving 2019). People will live with an increasing variety 
of technology products, and the patterns of usage of cur-
rent devices such as smartphones will change.
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Limitations of this review
There are limitations to this review. This is not a sys-
tematic review of mental health related studies using 
smartphones apps. Physician perspectives about recom-
mending technology, or the potential impacts of large 
amounts of patient data in the EMR on physician over-
load were not discussed. Measures related to improving 
the usability of apps, and long-term impacts of app use 
on patient trust were not included. Approaches to rat-
ing or recommending apps, legal issues related to app or 
technology errors, detailed regulatory issues, and tech-
nical issues related to privacy, security, and interoper-
ability standards were not discussed. Methodological 
issues related to the analysis of patient generated data, 
such as missing values, were not discussed. The require-
ment to engage in self-tracking outside of medicine, 
as by employers or insurers, was not discussed. Issues 
related to anonymization and re-identification of data, 
and sharing of research data collected from apps, were 
omitted. Finally, issues related to radiofrequency micro-
wave radiation exposure were not discussed, including 
cellphone safety limits, emissions when cellphones touch 
the body, increased absorption rates in children (Gandhi 
et  al. 2012; Gandhi 2019; Fernández et  al. 2018; Morris 
et al. 2015), and potential health effects from long-term 
exposure (Lin 2018). The article search for this review 
occurred between February–May, 2019.
Conclusions
The issues discussed in this paper suggest some recom-
mendations for the future of consumer use of technology 
in psychiatry.
Maximize patient choice of technology
The focus of technology in psychiatry should be on auto-
mating functions that will allow patient input or contact 
using many types of consumer technologies, respecting 
the patient’s lifestyle, budget and skill set. For example, 
those who can only afford intermittent smartphone ser-
vice may prefer to receive emails rather than text mes-
sages (Alcaraz et al. 2018). It is also important to consider 
that people of all ages with disabilities, including visual or 
motor impairments, may prefer to use technology other 
than a smartphone (Watanabe et  al. 2015; Trewin et  al. 
2013; Bauer et al. 2018a). Patient technologies for medi-
cine, including mental illness, should not exclude those 
with physical disabilities (Wolbring and Lashewicz 2014).
The era of personalized medicine should recognize that 
patients use and prefer different types of consumer tech-
nologies. A medication reminder system could send text 
messages to a smartphone or feature phone, email to a 
laptop, call a standard telephone, or connect with a voice 
assistant. In a US national sample, the most commonly 
used health technology in 2018 (by 59%) was to refill 
prescriptions (Abrams and Korba 2018), which would 
not require a smartphone. Due to the many limitations 
discussed above, analyses based on patient data should 
support many types of technologies, rather than focus-
ing on unregulated, sensor based measurements. A small 
amount of data could be entered from all commonly used 
consumer technologies, at a frequency such as daily or 
weekly.
Help to improve digital skills
A secondary benefit of recommending the use of tech-
nology to those with mental illness is to increase digital 
skills, and the use of multiple consumer technologies 
should be encouraged and supported. Some researchers 
feel that smartphone only access to the Internet is creat-
ing a new type of “mobile underclass” with fewer digital 
skills and more passive online involvement (Napoli and 
Obar 2014). Studies from diverse countries including 
The Netherlands and Chile report less information seek-
ing, active participation and variety of Internet use when 
access is only by smartphone (van Deursen and van Dijk 
2019; Correa et  al. 2018). In a US study of smartphone 
users over age 18, 87% of smartphone time was spent on 
apps and only 13% on the Internet (ComScore 2017b). 
Programs to help community integration of those with 
serious mental illness could include training on the safe 
use of technology.
Recommendations for the future
Increased understanding of the complex issues sur-
rounding consumer technologies is needed to success-
fully integrate apps into the practice of psychiatry. New 
methodologies must be defined and standardized to 
evaluate the efficacy of apps used for screening or treat-
ment. Regardless of the technology platform, only some 
patients will use the app. Given the realities of app 
accuracy, efficacy, privacy, security, and the regulatory 
environment, and to maximize participation, a variety 
of technology platforms should be used for data collec-
tion rather than focusing on smartphones. Develop-
ment should also include administrative apps that may 
increase care participation, and apps that educate about 
mental illness. App development requires multidiscipli-
nary expertise in medical, legal, consumer, and technical 
areas, with physicians and patients heavily involved in all 
phases, and large-scale testing in clinical settings.
Complete security information should be provided to 
patients before recommending any apps on any tech-
nology platform. Training and ongoing support from 
humans should be available for all recommended apps. 
Patients should be allowed to choose if they want their 
app data included in their EMR, shared with anyone 
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other than their psychiatrist, or used in research. Patient 
data from apps should not be transferred into EMR if 
insufficient IT resources are available to handle securely, 
or if unable to accommodate patient choice as to access 
and use. Finally, investment in programs to increase 
competence and comfort with technology for those with 
mental illness should be considered.
Acknowledgements
None.
Authors’ contributions
MB and TG completed the initial draft of the manuscript, which was reviewed 
by all authors. All authors read and approved the final manuscript.
Funding
None.
Ethics approval and consent to participate
Not applicable.
Consent for publication
The authors provide consent for publication.
Competing interests
JG reports grants from UK Medical Research Council, grants from Wellcome, 
grants from National Institute for Health Research, outside the submitted 
work; and led the conception of True Colours, a digital phenotyping and 
outcome assessment tool and has overseen its implementation in routine 
clinical practice and research studies. He is also a National Institute for Health 
Research Senior Investigator and Director of the NIHR Oxford Health Biomedi‑
cal Research Centre. LVK has been a consultant for Lundbeck within the last 
3 years. The other authors report no competing interests.
Author details
1 Department of Psychiatry and Psychotherapy, University Hospital Carl 
Gustav Carus, Medical Faculty, Technische Universität Dresden, Fetscherstr. 
74, 01307 Dresden, Germany. 2 ChronoRecord Association, Fullerton, CA, USA. 
3 Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, 
UK. 4 Department of Psychiatry and Biobehavioral Sciences, Semel Institute 
for Neuroscience and Human Behavior, University of California Los Angeles 
(UCLA), Los Angeles, CA, USA. 5 Mood Disorders Center of Ottawa, Ottawa, 
Canada. 6 Department of Psychiatry, University of Toronto, Toronto, ON, 
Canada. 7 Copenhagen Affective Disorder Research Center (CADIC), Psychiatric 
Center Copenhagen, Rigshospitalet, Copenhagen, Denmark. 8 Michigan State 
University College of Human Medicine, Traverse City Campus, Traverse City, 
MI, USA. 
Received: 26 July 2019   Accepted: 24 October 2019
References
Abdullah S, Choudhury T. Sensing technologies for monitoring serious mental 
illnesses. IEEE Multimedia. 2018;25:61–75.
Abrams K, Korba C. Consumers are on board with virtual health options. 
Deloitte Insights. 2018. https ://www2.deloi tte.com/insig hts/us/en/
indus try/healt h‑care/virtu al‑healt h‑care‑consu mer‑exper ience ‑surve 
y.html. Accessed 14 June 2019.
Abu Rahal Z, Vadas L, Manor I, Bloch B, Avital A. Use of information and com‑
munication technologies among individuals with and without serious 
mental illness. Psychiatry Res. 2018;266:160–7.
Achtyes ED, Ben‑Zeev D, Luo Z, Mayle H, Burke B, Rotondi AJ, et al. Off‑hours 
use of a smartphone intervention to extend support for individuals 
with schizophrenia spectrum disorders recently discharged from a 
psychiatric hospital. Schizophr Res. 2019;206:200–8.
ACM. USACM Issues statement on algorithmic transparency and account‑
ability. 2017. https ://www.acm.org/binar ies/conte nt/asset s/publi c‑polic 
y/2017_joint _state ment_algor ithms .pdf. Accessed 14 June 2019.
Agaku IT, Adisa AO, Ayo‑Yusuf OA, Connolly GN. Concern about security 
and privacy, and perceived control over collection and use of health 
information are related to withholding of health information from 
healthcare providers. J Am Med Inform Assoc. 2014;21:374–8.
Agu E, Pedersen P, Strong D, Tulu B, He Q, Wang L, et al. The smartphone as a 
medical device: assessing enablers, benefits and challenges. In: 2013 
IEEE international workshop of internet‑of‑things networking and 
control (IoT‑NC). IEEE; 2013 Jun 24. pp. 48–52.
Ahmed I, Ahmad NS, Ali S, Ali S, George A, Saleem Danish H, et al. Medication 
adherence apps: review and content analysis. JMIR Mhealth Uhealth. 
2018;6:e62.
AI HLEG. (EU High‑Level Expert Group on Artificial Intelligence). Ethics guide‑
lines for trustworthy AI. 2019. https ://ec.europ a.eu/digit al‑singl e‑marke 
t/en/news/ethic s‑guide lines ‑trust worth y‑ai. Accessed 14 June 2019.
Alcaraz KI, Riehman K, Vereen R, Bontemps‑Jones J, Westmaas JL. To text or 
not to text? technology‑based cessation communication preferences 
among urban, socioeconomically disadvantaged smokers. Ethn Dis. 
2018;28:161–8.
Alexander JC, Minhajuddin A, Joshi GP. Comparison of smartphone 
application‑based vital sign monitors without external hardware versus 
those used in clinical practice: a prospective trial. J Clin Monit Comput. 
2017;31:825–31.
Althoff T. Population‑scale pervasive health. IEEE Pervasive Comput. 
2017;16:75–9.
Alyami M, Giri B, Alyami H, Sundram F. Social anxiety apps: a systematic review 
and assessment of app descriptors across mobile store platforms. Evid 
Based Ment Health. 2017;20:65–70.
Amft O. How wearable computing is shaping digital health. IEEE Pervasive 
Comput. 2018;17:92–8.
Amft O, Van Laerhoven K. What will we wear after smartphones? IEEE Pervasive 
Comput. 2017;16:80–5.
Anderson M, Perrin A. Tech adoption climbs among older adults. Pew Research 
Centre. 2017. http://www.pewin terne t.org/2017/05/17/tech‑adopt ion‑
climb s‑among ‑older ‑adult s/. Accessed 14 June 2019.
Argaw ST, Bempong NE, Eshaya‑Chauvin B, Flahault A. The state of research on 
cyberattacks against hospitals and available best practice recommen‑
dations: a scoping review. BMC Med Inform Decis Mak. 2019;19:10.
Armontrout JA, Torous J, Cohen M, McNiel DE, Binder R. Current regulation 
of mobile mental health applications. J Am Acad Psychiatry Law. 
2018;46:204–11.
Barocas S, Nissenbaum H. Big data’s end run around procedural privacy pro‑
tections. Commun ACM. 2014;57:31–3.
Bauer M, Glenn T, Monteith S, Bauer R, Whybrow PC, et al. Ethical perspectives 
on recommending digital technology for patients with mental illness. 
Int J Bipolar Disord. 2017;5:6.
Bauer R, Glenn T, Strejilevich S, Conell J, Alda M, Ardau R, et al. Internet use 
by older adults with bipolar disorder: international survey results. Int J 
Bipolar Disord. 2018a;6:20.
Bauer M, Glenn T, Monteith S, Gottlieb JF, Ritter PS, Geddes J, et al. The poten‑
tial influence of LED lighting on mental illness. World J Biol Psychiatry. 
2018b;19:59–73.
Bauer M, Monteith S, Geddes J, Gitlin MJ, Grof P, Whybrow PC, et al. Automa‑
tion to optimise physician treatment of individual patients: examples in 
psychiatry. Lancet Psychiatry. 2019;6:338–49.
Beales H. The value of behavioral targeting. Netw Adv Initiat. 2010;1:1.
Beevi FH, Miranda J, Pedersen CF, Wagner S. An evaluation of commercial 
pedometers for monitoring slow walking speed populations. Telemed J 
E Health. 2016;22:441–9.
Behar JA, Oster J, De Vos M, Clifford GD. Wearables and mHealth in mental 
health and neurological disorders. Physiol Meas. 2019;40:070401.
Bell G. Bell’s law for the birth and death of computer classes: a theory of the 
computer’s evolution. IEEE Solid‑State Circ Soc Newsl. 2008;13:8–19.
Ben‑Zeev D, Wang R, Abdullah S, Brian R, Scherer EA, Mistler LA, et al. Mobile 
behavioral sensing for outpatients and inpatients with schizophrenia. 
Psychiatr Serv. 2016;67:558–61.
Berenguer A, Goncalves J, Hosio S, Ferreira D, Anagnostopoulos T, Kostakos 
V. Are Smartphones Ubiquitous?: an in‑depth survey of smartphone 
adoption by seniors. IEEE Consum Elect Magaz. 2017;6:104–10.
Page 15 of 19Bauer et al. Int J Bipolar Disord             (2020) 8:2 
Bhat S, Ferraris A, Gupta D, Mozafarian M, DeBari VA, Gushway‑Henry N, et al. 
Is there a clinical role for smartphone sleep apps? Comparison of sleep 
cycle detection by a smartphone application to polysomnography. J 
Clin Sleep Med. 2015;11:709–15.
Bondaronek P, Alkhaldi G, Slee A, Hamilton FL, Murray E. Quality of publicly 
available physical activity apps: review and content analysis. JMIR 
Mhealth Uhealth. 2018;6:e53.
Boonstra TW, Nicholas J, Wong QJ, Shaw F, Townsend S, Christensen H. Using 
mobile phone sensor technology for mental health research: integrated 
analysis to identify hidden challenges and potential solutions. J Med 
Internet Res. 2018;20:e10131.
Bouts AM, Brackman L, Martin E, Subasic AM, Potkanowicz ES. The accuracy 
and validity of ios‑based heart rate apps during moderate to high 
intensity exercise. Int J Exerc Sci. 2018;11:533–40.
Bowie‑DaBreo D, Sunram‑Lea SI, Sas C, Iles‑Smith H. A content analysis and 
ethical review of mobile applications for depression: exploring the app 
marketplace. 2019. http://eprin ts.lancs .ac.uk/13200 9/1/CMH_2019_
Sympo sium_Poste r_Dionn e_Bowie .pdf. Accessed 14 June 2019.
Brodie MA, Pliner EM, Ho A, Li K, Chen Z, Gandevia SC, et al. Big data vs accu‑
rate data in health research: large‑scale physical activity monitoring, 
smartphones, wearable devices and risk of unconscious bias. Med 
Hypotheses. 2018;119:32–6.
Bröhl C, Rasche P, Jablonski J, Kumar S, Wille M, Mertens A. Desktop PC, tablet 
PC, or smartphone? An analysis of use preferences in daily activities 
for different technology generations of a worldwide sample. In: Zhou 
J, Salvendy G, editors. Human aspects of IT for the aged population. 
acceptance, communication and participation. ITAP 2018. Lecture 
notes in computer science, vol. 10926. Cham: Springer; 2018.
Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 
2011;86:304–14.
Byambasuren O, Sanders S, Beller E, Glasziou P. Prescribable mHealth apps 
identified from an overview of systematic reviews. NPJ Digit Med. 
2018;1:12.
Carpenter‑Song E, Noel VA, Acquilano SC, Drake RE. Real‑world technology 
use among people with mental illnesses: qualitative study. JMIR Ment 
Health. 2018;5:e10652.
Carroll JK, Moorhead A, Bond R, LeBlanc WG, Petrella RJ, Fiscella K. Who uses 
mobile phone health apps and does use matter? A secondary data 
analytics approach. J Med Internet Res. 2017;19:e125.
Chapman C, Champion KE, Birrell L, Deen H, Brierley ME, Stapinski LA, et al. 
Smartphone apps about crystal methamphetamine (“ice”): systematic 
search in app stores and assessment of composition and quality. JMIR 
Mhealth Uhealth. 2018;6:e10442.
Charette RN. Healthcare IT systems: tempting targets for ransomware. IEEE 
Spectrum. Feb 1 2018. https ://spect rum.ieee.org/riskf actor /compu ting/
it/healt hcare ‑it‑syste ms‑tempt ing‑targe ts‑for‑ranso mware . Accessed 
14 June 2019.
Chen J, Cade JE, Allman‑Farinelli M. The most popular smartphone apps for 
weight loss: a quality assessment. JMIR Mhealth Uhealth. 2015;3:e104.
Choi YK, Demiris G, Lin SY, Iribarren SJ, Landis CA, Thompson HJ, et al. Smart‑
phone applications to support sleep self‑management: review and 
evaluation. J Clin Sleep Med. 2018;14:1783–90.
Cohen IG, Mello MM. HIPAA and protecting health information in the 21st 
century. JAMA. 2018;320:231–2.
Computer Economics. IT Spending as a percentage of revenue by industry, 
company size, and region. 2019. https ://www.compu terec onomi 
cs.com/artic le.cfm?id=2626. Accessed 14 June 2019.
comScore. The 2017 U.S. Cross‑Platform Future in Focus. 2017a. https ://www.
comsc ore.com/Insig hts/Prese ntati ons‑and‑White paper s/2017/2017‑
US‑Cross ‑Platf orm‑Futur e‑in‑Focus . Accessed 14 June 2019.
comScore. The 2017 US mobile app report. 2017b. https ://www.comsc ore.
com/Insig hts/Prese ntati ons‑and‑White paper s/2017/The‑2017‑US‑
Mobil e‑App‑Repor t. Accessed 14 June 2019.
Conell J, Bauer R, Glenn T, Alda M, Ardau R, Baune BT, et al. Online information 
seeking by patients with bipolar disorder: results from an international 
multisite survey. Int J Bipolar Disord. 2016;4:17.
Coppetti T, Brauchlin A, Müggler S, Attinger‑Toller A, Templin C, Schönrath F, 
et al. Accuracy of smartphone apps for heart rate measurement. Eur J 
Prev Cardiol. 2017;24:1287–93.
Cornet VP, Holden RJ. Systematic review of smartphone‑based passive sensing 
for health and wellbeing. J Biomed Inform. 2018;77:120–32.
Correa T, Pavez I, Contreras J. Digital inclusion through mobile phones?: a com‑
parison between mobile‑only and computer users in internet access, 
skills and use. Inf Commun Soc. 2018;19:1–8.
Crane D, Garnett C, Brown J, West R, Michie S. Behavior change techniques in 
popular alcohol reduction apps: content analysis. J Med Internet Res. 
2015;17:e118.
Davis J. FDA regulation of mobile apps. ABA (American Bar Association) 
Practice points. 2017. https ://www.ameri canba r.org/group s/litig ation /
commi ttees /produ cts‑liabi lity/pract ice/2017/fda‑regul ation ‑of‑mobil 
e‑medic al‑apps/. Accessed 14 June 2019.
Day S, Zweig M. Beyond wellness for the healthy: digital health consumer 
adoption 2018. 2019. Rock Health. https ://rockh ealth .com/repor ts/
beyon d‑welln ess‑for‑the‑healt hy‑digit al‑healt h‑consu mer‑adopt ion‑
2018/. Accessed 14 June 2019.
del Rosario MB, Redmond SJ, Lovell NH. Tracking the Evolution of smart‑
phone sensing for monitoring human movement. Sensors (Basel). 
2015;15:18901–33.
Deloitte. The App economy in the United States. 2018. https ://www.ftc.
gov/syste m/files /docum ents/publi c_comme nts/2018/08/ftc‑2018‑
0048‑d‑0121‑15529 9.pdf. Accessed 14 June 2019.
Di Matteo D, Fine A, Fotinos K, Rose J, Katzman M. Patient willingness to 
consent to mobile phone data collection for mental health apps: struc‑
tured questionnaire. JMIR Ment Health. 2018;5:e56.
Dogan E, Sander C, Wagner X, Hegerl U, Kohls E. Smartphone‑based monitor‑
ing of objective and subjective data in affective disorders: where are 
we and where are we going? Systematic review. J Med Internet Res. 
2017;19:e262.
DOJ (US Department of Justice). How to protect your networks from ransom‑
ware: interagency technical guidance document. 2016. https ://www.
justi ce.gov/crimi nal‑ccips /file/87277 1/downl oad. Accessed 14 June 
2019.
Donovan F. Healthcare continues to bear the brunt of ransomware attacks.
health it security. Health IT Security. 2018. https ://healt hitse curit y.com/
news/healt hcare ‑conti nues‑to‑bear‑the‑brunt ‑of‑ranso mware ‑attac ks. 
Accessed 14 June 2019.
Dragovic M, Davison S, Morgan VA, Chiu VW, Richards N, Vatskalis T. Validated, 
easy to use and free’: top three requests for mobile device applica‑
tions (‘apps’) from mental health consumers and clinicians. Adv Mental 
Health. 2018. https ://doi.org/10.1080/18387 357.2018.15570 14.
Elhai JD, Dvorak RD, Levine JC, Hall BJ. Problematic smartphone use: a con‑
ceptual overview and systematic review of relations with anxiety and 
depression psychopathology. J Affect Disord. 2017;207:251–9.
Elvy S. Commodifying consumer data in the era of the internet of things. 
2018. 59 Boston College Law Review 423 (2018). https ://ssrn.com/abstr 
act=30588 55. Accessed 14 June 2019.
Ernsting C, Dombrowski SU, Oedekoven M, Sullivan JL, Kanzler M, Kuhlmey 
A, et al. Using smartphones and health apps to change and man‑
age health behaviors: a population‑based survey. J Med Internet Res. 
2017;19:e101.
Etkin J. The hidden cost of personal quantification. J Consum Res. 
2016;42:967–84.
Executive Office. Big data: a report on algorithmic systems, opportunity, and 
civil rights. 2016. https ://obama white house .archi ves.gov/sites /defau lt/
files /micro sites /ostp/2016_0504_data_discr imina tion.pdf. Accessed 14 
June 2019.
Fair Warning. Canada Patient privacy survey. 2011b. https ://www.fairw arnin 
g.com/wp‑conte nt/uploa ds/2015/09/2011‑12‑WP‑CANAD A‑PATIE NT‑
SURVE Y1.pdf. Accessed 14 June 2019.
Fair Warning. UK Patient privacy survey. 2011a. https ://www.fairw arnin g.com/
wp‑conte nt/uploa ds/2015/09/2011‑10‑WP‑UK‑PATIE NT‑SURVE Y1.pdf. 
Accessed 14 June 2019.
Faurholt‑Jepsen M, Frost M, Vinberg M, Christensen EM, Bardram JE, Kessing LV. 
Smartphone data as objective measures of bipolar disorder symptoms. 
Psychiatry Res. 2014;217:124–7.
Faurholt‑Jepsen M, Frost M, Ritz C, Christensen EM, Jacoby AS, Mikkelsen 
RL, et al. Daily electronic self‑monitoring in bipolar disorder using 
smartphones—the MONARCA I trial: a randomized, placebo‑controlled, 
single‑blind, parallel group trial. Psychol Med. 2015;45:2691–704.
Faurholt‑Jepsen M, Bauer M, Kessing LV. Smartphone‑based objective moni‑
toring in bipolar disorder: status and considerations. Int J Bipolar Disord. 
2018;6(1):6.
Page 16 of 19Bauer et al. Int J Bipolar Disord             (2020) 8:2 
Faurholt‑Jepsen M, Frost M, Christensen EM, Bardram JE, Vinberg M, Kessing LV. 
The effect of smartphone‑based monitoring on illness activity in bipo‑
lar disorder: the MONARCA II randomized controlled single‑blinded 
trial. Psychol Med. 2019. https ://doi.org/10.1017/s0033 29171 90007 10.
FDA. FDA approves pill with sensor that digitally tracks if patients have 
ingested their medication. 2017a. https ://www.fda.gov/news‑event s/
press ‑annou nceme nts/fda‑appro ves‑pill‑senso r‑digit ally‑track s‑if‑patie 
nts‑have‑inges ted‑their ‑medic ation . Accessed 12 Sept 2019.
FDA. Is a new 510(k) required for a modification to the device? 2017b. https ://
www.fda.gov/medic al‑devic es/prema rket‑notifi cati on‑510k/new‑510k‑
requi red‑modifi cati on‑devic e. Accessed 14 June 2019.
Feehan LM, Geldman J, Sayre EC, Park C, Ezzat AM, Yoo JY, et al. Accuracy of 
Fitbit devices: systematic review and narrative syntheses of quantitative 
data. JMIR Mhealth Uhealth. 2018;6:e10527.
Felde M. Wearable medical devices give abundant data—and risks. The Doc‑
tors Company. 2019. https ://www.thedo ctors .com/artic les/weara ble‑
medic al‑devic es‑give‑abund ant‑dataa nd‑risks /. Accessed 14 June 2019.
Fernández C, de Salles AA, Sears ME, Morris RD, Davis DL. Absorption of wire‑
less radiation in the child versus adult brain and eye from cell phone 
conversation or virtual reality. Environ Res. 2018;167:694–9.
Ferron JC, Brunette MF, Geiger P, Marsch LA, Adachi‑Mejia AM, Bartels SJ. 
Mobile phone apps for smoking cessation: quality and usability among 
smokers with psychosis. JMIR Hum Factors. 2017;4(1):e7.
Firth J, Torous J. Smartphone apps for schizophrenia: a systematic review. JMIR 
Mhealth Uhealth. 2015;3:e102.
Fleming T, Bavin L, Lucassen M, Stasiak K, Hopkins S, Merry S. Beyond the trial: 
systematic review of real‑world uptake and engagement with digital 
self‑help interventions for depression, low mood, or anxiety. J Med 
Internet Res. 2018;20:e199.
Fokkema T, Kooiman TJ, Krijnen WP, Van Der Schans CP, Groot DE. Reliability 
and validity of ten consumer activity trackers depend on walking 
speed. Med Sci Sports Exerc. 2017;49:793–800.
Foster KR, Callans DJ. Smartphone apps meet evidence‑based medicine: the 
future of medicine may (or may not) be in your smartphone. IEEE Pulse. 
2017;8:34–9.
Frazee J, Finley M, Rohack JJ. mHealth and unregulated data: is this farewell to 
patient privacy. Ind Health L Rev. 2016;13:384.
FTC (US Federal Trade Commission). Mobile health apps interactive tool. 
Developing a mobile health app. 2016. https ://www.ftc.gov/tips‑advic 
e/busin ess‑cente r/guida nce/mobil e‑healt h‑apps‑inter activ e‑tool. 
Accessed 14 June 2019.
Gage D. The venture capital secret: 3 out of 4 start‑ups fail. Wall Street J. 
2012;19:20.
Gandhi OP. Microwave emissions from cell phones exceed safety lim‑
its in europe and the US when touching the body. IEEE Access. 
2019;7:47050–2.
Gandhi OP, Morgan LL, de Salles AA, Han YY, Herberman RB, Davis DL. 
Exposure limits: the underestimation of absorbed cell phone radiation, 
especially in children. Electromagn Biol Med. 2012;31:34–51.
Gangadharan SP. The downside of digital inclusion: expectations and experi‑
ences of privacy and surveillance among marginal Internet users. New 
Media Soc. 2017;19:597–615.
Gartner. Gartner Says worldwide wearable device sales to grow 26 percent 
in 2019. 2018. https ://www.gartn er.com/en/newsr oom/press ‑relea 
ses/2018‑11‑29‑gartn er‑says‑world wide‑weara ble‑devic e‑sales ‑to‑
grow‑. Accessed 14 June 2019.
Glenn T, Monteith S. New measures of mental state and behavior based 
on data collected from sensors, smartphones, and the Internet. Curr 
Psychiatry Rep. 2014a;16:523.
Glenn T, Monteith S. Privacy in the digital world: medical and health data 
outside of HIPAA protections. Curr Psychiatry Rep. 2014b;16:494.
Glick G, Druss B, Pina J, Lally C, Conde M. Use of mobile technology in a com‑
munity mental health setting. J Telemed Telecare. 2016;22:430–5.
Godfrey A, Hetherington V, Shum H, Bonato P, Lovell NH, Stuart S. From A to Z: 
wearable technology explained. Maturitas. 2018;113:40–7.
Gonzales A. The contemporary US digital divide: from initial access to technol‑
ogy maintenance. Inf Commun Soc. 2016;19:234–48.
Goodday SM, Cipriani A. Challenges in identifying behavioural markers of 
bipolar disorder through objective smartphone data. Aust N Z J Psy‑
chiatry. 2019;53:168–9.
Google. 2016. This year’s Founders’ Letter. 2016. https ://www.blog.googl e/insid 
e‑googl e/alpha bet/this‑years ‑found ers‑lette r/. Accessed 14 June 2019.
Gostin LO, Halabi SF, Wilson K. Health data and privacy in the digital era. JAMA. 
2018;320:233–4.
GPS.gov. GPS Accuracy. 2017. https ://www.gps.gov/syste ms/gps/perfo rmanc 
e/accur acy/. Accessed 14 June 2019.
Grammenos A, Mascolo C, Crowcroft J. You are sensing, but are you biased?: a 
user unaided sensor calibration approach for mobile sensing. Proc ACM 
Interact Mob Wearable Ubiquitous Technol. 2018;2:11.
Grewal M, Andrews A. How good is your gyro [ask the experts]. IEEE Control 
Syst Mag. 2010;30:12–86.
Gringras P, Middleton B, Skene DJ, Revell VL. Bigger, brighter, bluer‑better? Cur‑
rent light‑emitting devices—adverse sleep properties and preventative 
strategies. Front Public Health. 2015;3:233.
Grundy Q, Chiu K, Held F, Continella A, Bero L, Holz R. Data sharing practices of 
medicines related apps and the mobile ecosystem: traffic, content, and 
network analysis. BMJ. 2019;364:l920.
Gruwez A, Bruyneel AV, Bruyneel M. The validity of two commercially‑available 
sleep trackers and actigraphy for assessment of sleep parameters in 
obstructive sleep apnea patients. PLoS ONE. 2019;14:e0210569.
GSMA (Groupe Spéciale Mobile). The mobile economy 2018. 2018a. https ://
www.gsma.com/mobil eecon omy/. Accessed 14 June 2019.
GSMA. Consumer Insights. Evaluating mobile engagement. 2018b. https ://
www.gsmai ntell igenc e.com/resea rch/2018/02/consu mer‑insig hts‑
evalu ating ‑mobil e‑engag ement /661/. Accessed 14 June 2019.
Harrison PJ, Cipriani A, Harmer CJ, Nobre AC, Saunders K, Goodwin GM, et al. 
Innovative approaches to bipolar disorder and its treatment. Ann N Y 
Acad Sci. 2016;1366:76–89.
Hendrikoff L, Kambeitz‑Ilankovic L, Pryss R, Senner F, Falkai P, Pogarell O, et al. 
Prospective acceptance of distinct mobile mental health features in 
psychiatric patients and mental health professionals. J Psychiatr Res. 
2019;109:126–32.
Herbert R, Kim JH, Kim YS, Lee HM, Yeo WH. Soft material‑enabled, flexible 
hybrid electronics for medicine, healthcare, and human‑machine 
interfaces. Materials. 2018;11:187.
HHS (US Department of Health & Human Services). Health care industry 
cybersecurity task force. Report on improving cybersecurity in the 
health care industry. 2017. https ://www.phe.gov/Prepa redne ss/plann 
ing/Cyber TF/Pages /defau lt.aspx. Accessed 14 June 2019.
Hill S. Can you really trust app store ratings? We asked the experts. Digital 
Trends. 2018. https ://www.digit altre nds.com/andro id/can‑you‑reall 
y‑trust ‑app‑store ‑ratin gs/. Accessed 14 June 2019.
HIPAA Journal. Security breach highlights need for patient portals to be pen 
tested. 2017. https ://www.hipaa journ al.com/secur ity‑breac h‑highl ights 
‑need‑for‑patie nt‑porta ls‑to‑be‑pen‑teste d‑8803/. Accessed 14 June 
2019.
Hitlin P, Rainie L. Facebook algorithms and personal data. Pew Research Center. 
2019. https ://www.pewin terne t.org/2019/01/16/faceb ook‑algor ithms 
‑and‑perso nal‑data/. Accessed 14 June 2019.
Huckvale K, Torous J, Larsen ME. Assessment of the data sharing and privacy 
practices of smartphone apps for depression and smoking cessation. 
JAMA Netw Open. 2019;2:e192542.
Hughes JF. How wearables could put doctors in HIPAA hot water. Physi‑
cianSense. 2019. https ://www.mdlin x.com/physi cians ense/how‑weara 
bles‑could ‑put‑docto rs‑in‑hipaa ‑hot‑water /. Accessed 14 June 2019.
Huguet A, Rao S, McGrath PJ, Wozney L, Wheaton M, Conrod J, Rozario S. A 
systematic review of cognitive behavioral therapy and behavioral acti‑
vation apps for depression. PLoS ONE. 2016;11(5):e0154248.
Hwang K. Dangers of defective mobile health apps and devices. Verywell. 
2018. https ://www.veryw ellhe alth.com/dange rs‑of‑defec tive‑mobil 
e‑healt h‑apps‑and‑devic es‑17391 51. Accessed 14 June 2019.
IDC. Ongoing demand fuels a strong growth trajectory for wearable devices in 
q1 2019 with wrist‑worn and ear‑worn leading the market, according 
to IDC. 2019. https ://www.idc.com/getdo c.jsp?conta inerI d=prUS4 
51150 19. Accessed 14 June 2019.
Irving D. What the speed of life means for security and society. Rand Review, 
2019. https ://www.rand.org/blog/rand‑revie w/2019/03/what‑the‑
speed ‑of‑life‑means ‑for‑secur ity‑and‑socie ty.html. Accessed 14 June 
2019.
Page 17 of 19Bauer et al. Int J Bipolar Disord             (2020) 8:2 
Kertz SJ, Kelly JM, Stevens KT, Schrock M, Danitz SB. A review of free iPhone 
applications designed to target anxiety and worry. J Technol Behav Sci. 
2017;2:61.
Kim J, Seo M, David P. Alleviating depression only to become problematic 
mobile phone users: can face‑to‑face communication be the antidote? 
Comput Human Behav. 2015;51:440–7.
Klasnja P, Consolvo S, Choudhury T, Beckwith R, Hightower J. Exploring privacy 
concerns about personal sensing. International conference on perva‑
sive computing. Berlin: Springer; 2009. p. 176–83.
Klee A, Stacy M, Rosenheck R, Harkness L, Tsai J. Interest in technology‑based 
therapies hampered by access: a survey of veterans with serious mental 
illnesses. Psychiatr Rehabil J. 2016;39:173–9.
Koetsier J. Google vs Amazon at CES: the battle for the future of voice (and 
computing). Forbes. 2019. https ://www.forbe s.com/sites /johnk oetsi 
er/2019/01/11/googl e‑vs‑amazo n‑at‑ces‑the‑battl e‑for‑the‑futur e‑of‑
voice ‑and‑compu ting/#4f85d 4143c 68. Accessed 14 June 2019.
Kos A, Tomažič S, Umek A. Evaluation of smartphone inertial sensor per‑
formance for cross‑platform mobile applications. Sensors (Basel). 
2016;16:477.
Krebs P, Duncan DT. Health app use among us mobile phone owners: a 
national survey. JMIR Mhealth Uhealth. 2015;3:e101.
Kretzschmar K, Tyroll H, Pavarini G, Manzini A, Singh I, Neurox young people’s 
advisory group. Can your phone be your therapist? Young people’s 
ethical perspectives on the use of fully automated conversational 
agents (chatbots) in mental health support. Biomed Inform Insights. 
2019;11:1178222619829083.
Kuerbis A, Mulliken A, Muench F, Moore AA, Gardner D. Older adults and 
mobile technology: factors that enhance and inhibit utilization in the 
context of behavioral health. Ment Heal Addict Res. 2017;2:1–11.
Lamkin P. Smart wearables market to double by 2022: $27 billion industry 
forecast. Forbes. 2018. https ://www.forbe s.com/sites /paull amkin 
/2018/10/23/smart ‑weara bles‑marke t‑to‑doubl e‑by‑2022‑27‑billi on‑
indus try‑forec ast/#1736e de726 56. Accessed 14 June 2019.
Larsen ME, Nicholas J, Christensen H. A systematic assessment of smartphone 
tools for suicide prevention. PLoS ONE. 2016a;11:e0152285.
Larsen ME, Nicholas J, Christensen H. Quantifying app store dynamics: 
longitudinal tracking of mental health apps. JMIR Mhealth Uhealth. 
2016b;4:e96.
Larsen ME, Huckvale K, Nicholas J, Torous J, Birrell L, Li E, Reda B. Using science 
to sell apps: evaluation of mental health app store quality claims. NPJ 
Dig Med. 2019;2:18.
Lee TT, Kesselheim ASUS. Food and Drug Administration precertification pilot 
program for digital health software: weighing the benefits and risks. 
Ann Intern Med. 2018;168:730–2.
Lee I, Lee Y. Circuit design in mm‑scale sensor platform for future IoT applica‑
tions. In: Kyung CM, Yasuura H, Liu Y, Lin YL, editors. Smart Sensors and 
Systems. Cham: Springer; 2017. p. 57–81.
Li X, Ortiz PJ, Browne J, Franklin D, Oliver JY, Geyer R, et al. Smartphone evolu‑
tion and reuse: Establishing a more sustainable model. In: 39th Interna‑
tional conference on parallel processing workshops. 2010, pp. 476–484.
Liang Z, Martell MA. Validity of consumer activity wristbands and wearable 
EEG for measuring overall sleep parameters and sleep structure in free‑
living conditions. J Healthc Inform Res. 2018;2:152–78.
Lin JC. Clear evidence of cell phone RF radiation cancer risk [health matters]. 
IEEE Microw Mag. 2018;19:6–24.
Lipschitz J, Miller CJ, Hogan TP, Burdick KE, Lippin‑Foster R, Simon SR, et al. 
Adoption of mobile apps for depression and anxiety: cross‑sectional 
survey study on patient interest and barriers to engagement. JMIR 
Ment Health. 2019;6:e11334.
Lowe SA, Ólaighin G. Monitoring human health behaviour in one’s living envi‑
ronment: a technological review. Med Eng Phys. 2014;36:147–68.
Lupton D. The digitally engaged patient: self‑monitoring and self‑care in the 
digital health era. Soc Theory Health. 2013;11:256–70.
Luxton DD, McCann RA, Bush NE, Mishkind MC, Reger GM. mHealth for mental 
health: integrating smartphone technology. Prof Psychol Res Pract. 
2011;42:505–12.
Mack CA. Fifty years of Moore’s law. IEEE Trans Semicond Manuf. 
2011;24:202–7.
Mandrola J, Foy A. Downsides of detecting atrial fibrillation in asymptomatic 
patients. Am Fam Physician. 2019;99:354–5.
Marakhimov A, Joo J. Consumer adaptation and infusion of wearable devices 
for healthcare. Comput Human Behav. 2017;76:135–48.
Martinez‑Martin N, Kreitmair K. Ethical issues for direct‑to‑consumer digital 
psychotherapy apps: addressing accountability, data protection, and 
consent. JMIR Ment Health. 2018;5:e32.
McCoy TH Jr, Perlis RH. Temporal trends and characteristics of reportable 
health data breaches, 2010–2017. JAMA. 2018;320:1282–4.
MicroMD. The HIPAA compliance of wearable technology. blogMD. 2019. https 
://www.micro md.com/blogm d/hipaa ‑compl iance ‑of‑weara ble‑techn 
ology /. Accessed 14 June 2019.
Minen MT, Stieglitz EJ, Sciortino R, Torous J. Privacy issues in smartphone 
applications: an analysis of headache/migraine applications. Headache. 
2018;58:1014–27.
Miner AS, Milstein A, Schueller S, Hegde R, Mangurian C, Linos E. Smartphone‑
based conversational agents and responses to questions about mental 
health, interpersonal violence, and physical health. JAMA Intern Med. 
2016;176:619–25.
Mohr DC, Zhang M, Schueller SM. Personal sensing: understanding mental 
health using ubiquitous sensors and machine learning. Annu Rev Clin 
Psychol. 2017;13:23–47.
Monteith S, Glenn T. Automated decision‑making and big data: concerns for 
people with mental illness. Curr Psychiatry Rep. 2016;18:112.
Monteith S, Glenn T, Geddes J, Whybrow PC, Bauer M. Big data for bipolar 
disorder. Int J Bipolar Disord. 2016;4:10.
Moore GE. Cramming more components onto integrated circuits, reprinted 
from electronics. IEEE Solid‑State Circ Newsl. 2006;3:33–5.
Morris RD, Morgan LL, Davis D. Children absorb higher doses of radio fre‑
quency electromagnetic radiation from mobile phones than adults. 
IEEE Access. 2015;3:2379–87.
Murakami H, Kawakami R, Nakae S, Nakata Y, Ishikawa‑Takata K, Tanaka S, 
Miyachi M. Accuracy of wearable devices for estimating total energy 
expenditure: comparison with metabolic chamber and doubly labeled 
water method. JAMA Intern Med. 2016;176:702–3.
Napoli PM, Obar JA. The emerging mobile internet underclass: a critique of 
mobile internet access. Inf Soc. 2014;30:323–34.
Narayanan A. When the business model *is* the privacy violation. Freedom 
to Tinker. Princeton Center for Information Technology Policy. 2018. 
https ://freed om‑to‑tinke r.com/2018/04/12/when‑the‑busin ess‑model 
‑is‑the‑priva cy‑viola tion/. Accessed 14 June 2019.
NASA. This week at NASA. 2012. https ://www.nasa.gov/multi media /podca 
sting /TWAN_11_23_12.html. Accessed 14 June 2019.
Nicholas J, Larsen ME, Proudfoot J, Christensen H. Mobile apps for bipolar 
disorder: a systematic review of features and content quality. J Med 
Internet Res. 2015;17(8):e198.
Oh JH, Yoo H, Park HK, Do YR. Analysis of circadian properties and healthy 
levels of blue light from smartphones at night. Sci Rep. 2015;5:11325.
O’Loughlin K, Neary M, Adkins EC, Schueller SM. Reviewing the data security 
and privacy policies of mobile apps for depression. Internet Interv. 
2019;15:110–5.
Packer M. What did the Apple heart study really find? MedPage Today. 
2019. https ://www.medpa getod ay.com/blogs /revol ution andre velat 
ion/78684 . Accessed 14 June 2019.
Parker L, Bero L, Gillies D, Raven M, Mintzes B, Jureidini J, et al. Mental 
health messages in prominent mental health apps. Ann Fam Med. 
2018;16:338–42.
Parker L, Bero L, Gillies D, Raven M, Grundy Q. The, “hot potato” of mental 
health app regulation: a critical case study of the Australian policy 
arena. Int J Health Policy Manag. 2019;8:168–76.
Parpinel M, Scherling L, Lazzer S, Della Mea V. Reliability of heart rate mobile 
apps in young healthy adults: exploratory study and research direc‑
tions. J Innov Health Inform. 2017;24:921.
Partnership on AI. Report on algorithmic risk assessment tools in the U.S. 
criminal justice system. 2019. https ://www.partn ershi ponai .org/repor 
t‑on‑machi ne‑learn ing‑in‑risk‑asses sment ‑tools ‑in‑the‑u‑s‑crimi nal‑justi 
ce‑syste m/. Accessed 14 June 2019.
Patel V, Johnson C. Individuals’ use of online medical records and technology 
for health needs. ONC Data Brief, no. 40. Washington: Office of the 
National Coordinator for Health Information Technology; 2018.
Patel N. 90% Of Startups Fail: Here’s What You Need To Know About 
The 10%. Forbes. 2015. https ://www.forbe s.com/sites /neilp 
Page 18 of 19Bauer et al. Int J Bipolar Disord             (2020) 8:2 
atel/2015/01/16/90‑of‑start ups‑will‑fail‑heres ‑what‑you‑need‑to‑know‑
about ‑the‑10/#53338 7ff66 79. Accessed 14 June 2019.
Patel V, Hughes P, Barker W, Moon L. Trends in individuals’ perceptions regard‑
ing privacy and security of medical records and exchange of health 
information: 2012–2014. ONC Data Brief, no. 33. Washington DC: Office 
of the National Coordinator for Health Information Technology; 2016.
PCAST (President’s Council of Advisors on Science and Technology). Big data 
and privacy: a technological perspective. 2014. https ://obama white 
house .archi ves.gov/sites /defau lt/files /micro sites /ostp/PCAST /pcast 
_big_data_and_priva cy_‑_may_2014.pdf. Accessed 14 June 2019.
Perez S. Report: Voice assistants in use to triple to 8 billion by 2023. Tech‑
Crunch. 2019. https ://techc runch .com/2019/02/12/repor t‑voice ‑assis 
tants ‑in‑use‑to‑tripl e‑to‑8‑billi on‑by‑2023/. Accessed 14 June 2019.
Pew Research. Mobile Fact Sheet. 2018. http://www.pewin terne t.org/fact‑
sheet /mobil e/. Accessed 14 June 2019.
Plante TB, Urrea B, MacFarlane ZT, Blumenthal RS, Miller ER 3rd, Appel LJ, et al. 
Validation of the instant blood pressure smartphone app. JAMA Intern 
Med. 2016;176:700–2.
Plante TB, O’Kelly AC, Macfarlane ZT, Urrea B, Appel LJ, Miller ER III, et al. Trends 
in user ratings and reviews of a popular yet inaccurate blood pressure‑
measuring smartphone app. J Am Med Inform Assoc. 2018;25:1074–9.
Posadzki P, Mastellos N, Ryan R, Gunn LH, Felix LM, Pappas Y, et al. Automated 
telephone communication systems for preventive healthcare and 
management of long‑term conditions. Cochrane Database Syst Rev. 
2016;12:CD009921.
Powell AC, Singh P, Torous J. The complexity of mental health app privacy poli‑
cies: a potential barrier to privacy. JMIR Mhealth Uhealth. 2018;6:e158.
Pratap A, Renn BN, Volponi J, Mooney SD, Gazzaley A, Arean PA, et al. Using 
mobile apps to assess and treat depression in Hispanic and Latino 
populations: fully remote randomized clinical trial. J Med Internet Res. 
2018;20:e10130.
Pratap A, Atkins DC, Renn BN, Tanana MJ, Mooney SD, Anguera JA, et al. The 
accuracy of passive phone sensors in predicting daily mood. Depress 
Anxiety. 2019;36:72–81.
Prayag AS, Najjar RP, Gronfier C. Melatonin suppression is exquisitely sensitive 
to light and primarily driven by melanopsin in humans. J Pineal Res. 
2019;66:e12562.
Puentes J, Montagner J, Lecornu L, Lähteenmäki J. Quality analysis of sensors 
data for personal health records on mobile devices. In: Bali R, Troshani 
I, Goldberg S, Wickramasinghe N, editors. Pervasive health knowledge 
management. New York: Springer; 2013. p. 103–33.
Rasche P, Wille M, Bröhl C, Theis S, Schäfer K, Knobe M, et al. Prevalence of 
health app use among older adults in Germany: national survey. JMIR 
Mhealth Uhealth. 2018;6:e26.
Research2Guidance. 325,000 mobile health apps available in 2017—Android 
now the leading mHealth platform. 2018. https ://resea rch2g uidan 
ce.com/32500 0‑mobil e‑healt h‑apps‑avail able‑in‑2017/. Accessed 14 
June 2019.
Research2Guidance. mHealth App Economics. Current status and future 
trends in mobile health. 2017. https ://resea rch2g uidan ce.com. 
Accessed 14 June 2019.
Research2Guidance. mHealth Economics Research Program. 2016. https ://
resea rch2g uidan ce.com. Accessed 14 June 2019.
Robbins R, Krebs P, Jagannathan R, Jean‑Louis G, Duncan DT. Health app use 
among us mobile phone users: analysis of trends by chronic disease 
status. JMIR Mhealth Uhealth. 2017;5:e197.
Roberts JJ. The business of your face. Fortune. 2019. http://fortu ne.com/longf 
orm/facia l‑recog nitio n/. Accessed 14 June 2019.
Robillard JM, Feng TL, Sporn AB, Lai JA, Lo C, Ta M, et al. Availability, readability, 
and content of privacy policies and terms of agreements of mental 
health apps. Internet Interv. 2019;6(17):100243.
Rodde T. 25% of users abandon an app after one use. 2019. Localytics. http://
info.local ytics .com/blog/25‑of‑users ‑aband on‑apps‑after ‑one‑use. 
Accessed 14 June 2019.
Rohani DA, Faurholt‑Jepsen M, Kessing LV, Bardram JE. Correlations between 
objective behavioral features collected from mobile and wearable 
devices and depressive mood symptoms in patients with affective 
disorders: systematic review. JMIR Mhealth Uhealth. 2018;6:e165.
Rosenfeld L, Torous J, Vahia IV. Data security and privacy in apps for demen‑
tia: an analysis of existing privacy policies. Am J Geriatr Psychiatry. 
2017;25:873–7.
Rowland C. Apple now says its smartwatch tech to detect atrial fibrillation is 
not for those with atrial fibrillation. Washington Post. 12/6/2018. https 
://www.washi ngton post.com/busin ess/econo my/apple ‑now‑says‑its‑
smart watch app‑to‑detec t‑atria l‑fibri llati on‑is‑not‑for‑those ‑with‑atria 
lfibr illat ion/2018/12/06/cb5c4 6bc‑f978‑11e8‑8c9a‑860ce 2a814 8f_story 
.html. Accessed 14 June 2019.
RSA. RSA Data Privacy and Security Survey 2019: the growing data discon‑
nect between customers and businesses. 2019. https ://www.rsa.com/
conte nt/dam/en/misc/rsa‑data‑priva cy‑and‑secur ity‑surve y‑2019.pdf. 
Accessed 14 June 2019.
Savov V. Apple and Samsung feel the sting of plateauing smartphones. The 
Verge. 2019. https ://www.theve rge.com/2019/1/3/18166 399/iphon 
e‑andro id‑apple ‑samsu ng‑smart phone ‑sales ‑peak. Accessed 14 June 
2019.
Schueller SM, Neary M, O’Loughlin K, Adkins EC. Discovery of and interest in 
health apps among those with mental health needs: survey and focus 
group study. J Med Internet Res. 2018;20:e10141.
Scott N, Cerulus L, Overly S. How Silicon Valley gamed Europe’s privacy rules. 
5/22/19. Politico. https ://www.polit ico.eu/artic le/europ e‑data‑prote 
ction ‑gdpr‑gener al‑data‑prote ction ‑regul ation ‑faceb ook‑googl e/. 
Accessed 14 June 2019.
Seppälä J, De Vita I, Jämsä T, Miettunen J, Isohanni M, Rubinstein K, et al. 
Mobile phone and wearable sensor‑based mhealth approaches for 
psychiatric disorders and symptoms: systematic review. JMIR Ment 
Health. 2019;6:e9819.
Shapiro R, Aneja S. Who owns Americans’ personal information and what is it 
worth? EconVue. 2019. https ://econv ue.com/pulse /who‑owns‑ameri 
cans%E2%80%99‑perso nal‑infor matio n‑and‑what‑it‑worth . Accessed 
14 June 2019.
Sheng S, Holbrook M, Kumaraguru P, Cranor LF, Downs J. Who falls for phish?: 
a demographic analysis of phishing susceptibility and effectiveness of 
interventions. In: Proceedings of the SIGCHI conference on human fac‑
tors in computing systems. ACM; 2010 Apr 10. pp. 373–82.
Singer N, Merrill JB. When a company is put up for sale, in many cases, your 
personal data is, too. New York Times. 2015. https ://www.nytim 
es.com/2015/06/29/techn ology /when‑a‑compa ny‑goes‑up‑for‑sale‑in‑
many‑cases ‑so‑does‑your‑perso nal‑data.html. Accessed 14 June 2019.
Singh K, Drouin K, Newmark LP, Lee J, Faxvaag A, Rozenblum R, et al. Many 
mobile health apps target high‑need, high‑cost populations, but gaps 
remain. Health Aff (Millwood). 2016;35:2310–8.
Singh K, Diamantidis CJ, Ramani S, Bhavsar NA, Mara P, Warner J, et al. Patients’ 
and nephrologists’ evaluation of patient‑facing smartphone apps for 
CKD. Clin J Am Soc Nephrol. 2019;14:523–9.
Smith A. Public attitudes toward computer algorithms. Pew Research Center. 
2018. https ://www.pewin terne t.org/2018/11/16/publi c‑attit udes‑towar 
d‑compu ter‑algor ithms /. Accessed 14 June 2019.
Snell E. Patient data breach fear hinders health data sharing. HealthITSecurity. 
2017. https ://healt hitse curit y.com/news/patie nt‑data‑breac h‑fear‑
hinde rs‑healt h‑data‑shari ng. Accessed 14 June 2019.
Solomon R, Sandborn PA, Pecht MG. Electronic part life cycle concepts 
and obsolescence forecasting. IEEE Trans Compon Packag Technol. 
2000;23:707–17.
Statistica. Adult wearable users penetration rate in the United States from 
2016 to 2022. 2019c. https ://www.stati sta.com/stati stics /79380 0/us‑
adult ‑weara ble‑penet ratio n/. Accessed 14 June 2019.
Statistica. Number of apps available in leading app stores as of 3rd quarter 
2018. 2019a. https ://www.stati sta.com/stati stics /27662 3/numbe r‑of‑
apps‑avail able‑in‑leadi ng‑app‑store s/. Accessed 14 June 2019.
Statistica. Worldwide mobile app retention rate during the first 90 days of 
ownership as of March 2016, by mobile platform. 2019b. https ://www.
stati sta.com/stati stics /24372 8/world wide‑mobil e‑app‑user‑reten tion‑
by‑mobil e‑plafo rm/. Accessed 14 June 2019.
Sucala M, Cuijpers P, Muench F, Cardoș R, Soflau R, Dobrean A, et al. Anxiety: 
there is an app for that. A systematic review of anxiety apps. Depress 
Anxiety. 2017;34:518–25.
Swearingen J. We’re no longer in smartphone plateau. we’re in the smart‑
phone decline. New York Magazine. 2018. https ://nymag .com/intel ligen 
cer/2018/12/globa l‑u‑s‑growt h‑in‑smart phone ‑growt h‑start s‑to‑decli 
ne.html. Accessed 14 June 2019.
Page 19 of 19Bauer et al. Int J Bipolar Disord             (2020) 8:2 
Terry NP. A healthcare frame for the Boeing crashes. Harvard Bill of Health Blog. 
2019. http://blog.petri eflom .law.harva rd.edu/2019/04/08/a‑healt hcare 
‑frame ‑for‑the‑boein g‑crash es/. Accessed 14 June 2019.
Thornton LK, Kay‑Lambkin FJ. Specific features of current and emerging 
mobile health apps: user views among people with and without men‑
tal health problems. Mhealth. 2018;4:56.
Toner J. Exploring the dark‑side of fitness trackers: normalization, objectifica‑
tion and the anaesthetisation of human experience. Perform Enhanc 
Health. 2018;6:75–81.
Toon E, Davey MJ, Hollis SL, Nixon GM, Horne RS, Biggs SN. Comparison of 
commercial wrist‑based and smartphone accelerometers, actigraphy, 
and psg in a clinical cohort of children and adolescents. J Clin Sleep 
Med. 2016;12:343–50.
Torous J, Roberts LW. The ethical use of mobile health technology in clinical 
psychiatry. J Nerv Ment Dis. 2017;205:4–8.
Torous J, Wisniewski H, Liu G, Keshavan M. Mental health mobile phone app 
usage, concerns, and benefits among psychiatric outpatients: compara‑
tive survey study. JMIR Ment Health. 2018;5:e11715.
Tosini G, Ferguson I, Tsubota K. Effects of blue light on the circadian system 
and eye physiology. Mol Vis. 2016;22:61–72.
Trewin S, Swart C, Pettick D. Physical accessibility of touchscreen smartphones. 
In: Proceedings of the 15th international ACM SIGACCESS conference 
on computers and accessibility. ACM; 2013 Oct 21, p. 19.
Valdez AC, Ziefle M. The users’ perspective on the privacy‑utility trade‑
offs in health recommender systems. Int J Hum Comput Stud. 
2019;121:108–21.
van Deursen AJ, van Dijk JA. The first‑level digital divide shifts from inequalities 
in physical access to inequalities in material access. New Media Soc. 
2019;21(2):354–7.
Vesnic‑Alujevic L, Breitegger M, Guimarães Pereira A. Do‑It‑Yourself’ health‑
care? quality of health and healthcare through wearable sensors. Sci 
Eng Ethics. 2018;24:887–904.
Vezočnik M, Juric MB. Average step length estimation models’ evaluation using 
inertial sensors: a review. IEEE Sens J. 2019;19(2):396–403.
Vinocur N. How one country blocks the world on data privacy. Politico. 
2019. https ://www.polit ico.com/story /2019/04/24/irela nd‑data‑priva 
cy‑12701 23. Accessed 14 June 2019.
Wahle F, Kowatsch T, Fleisch E, Rufer M, Weidt S. Mobile sensing and support 
for people with depression: a pilot trial in the wild. JMIR Mhealth 
Uhealth. 2016;4:e111.
Wang K, Varma DS, Prosperi M. A systematic review of the effectiveness of 
mobile apps for monitoring and management of mental health symp‑
toms or disorders. J Psychiatr Res. 2018;107:73–8.
Watanabe T, Yamaguchi T, Minatani K. Advantages and drawbacks of smart‑
phones and tablets for visually impaired people: analysis of ict user 
survey results. IEICE Trans Inf Syst. 2015;98:922–9.
Wiggers K, Top 10 products at CES 2019 that work with Alexa or Google 
Assistant. VentureBeat. 2019. https ://ventu rebea t.com/2019/01/13/
top‑5‑produ cts‑revea led‑at‑ces‑2019‑that‑work‑with‑alexa ‑and‑googl 
e‑assis tant/. Accessed 14 June 2019.
Wilson H, Stoyanov SR, Gandabhai S, Baldwin A. The quality and accuracy of 
mobile apps to prevent driving after drinking alcohol. JMIR Mhealth 
Uhealth. 2016;4(3):e98.
Wisniewski H, Liu G, Henson P, Vaidyam A, Hajratalli NK, Onnela JP, et al. 
Understanding the quality, effectiveness and attributes of top‑rated 
smartphone health apps. Evid Based Ment Health. 2019;22:4–9.
Wolbring G, Lashewicz B. Home care technology through an ability expecta‑
tion lens. J Med Internet Res. 2014;16(6):e155.
Yu JS, Kuhn E, Miller KE, Taylor K. Smartphone apps for insomnia: examining 
existing apps’ usability and adherence to evidence‑based principles for 
insomnia management. Transl Behav Med. 2019;9:110–9.
Zhang M, Ying J, Song G, Fung DS, Smith H. Attention and cognitive bias 
modification apps: review of the literature and of commercially avail‑
able apps. JMIR Mhealth Uhealth. 2018;6:e10034.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub‑
lished maps and institutional affiliations.
